![Paul-Henry Schmelck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul-Henry Schmelck
Plus aucun poste en cours
Profil
Dr. Paul-Henry Schmelck, MD, is Directeur de Participations at OTC Asset Management SA in France.
He received his doctorate degree from Université Paris, and a graduate degree from Université Paris.
Anciens postes connus de Paul-Henry Schmelck
| Sociétés | Poste | Fin |
|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Directeur/Membre du Conseil | 08/03/2010 |
Apicap SAS
 Apicap SAS Investment ManagersFinance Apicap invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for early, later, LBO and growth stage capital requirements. It also makes minority interests. | Private Equity Investor | 01/10/2009 |
PrimeBioTech
 PrimeBioTech Medical DistributorsDistribution Services Develops therapeutic products based on gene therapy technologies | President | 01/01/2004 |
| NANOBIOTIX | Corporate Officer/Principal | - |
| NEOVACS | Directeur/Membre du Conseil | - |
Formation de Paul-Henry Schmelck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Apicap SAS
Apicap SAS Investment ManagersFinance Apicap invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for early, later, LBO and growth stage capital requirements. It also makes minority interests. | Finance |
PrimeBioTech
PrimeBioTech Medical DistributorsDistribution Services Develops therapeutic products based on gene therapy technologies | Distribution Services |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Health Technology |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
